The UCLA Biomarker Innovations Laboratory (BIL) is one of the Sarkaria Biomarker Laboratories established in 2005 through a major endowment of Drs. Daljit and Elaine Sarkaria for translational research and innovation in clinical biomarkers. The BIL is a California state licensed and CLIA-certified clinical laboratory founded by Drs. Scott Binder and David Seligson, pathologist-scientists, and is located at one of the world's leading hospitals and academic institutions – the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Please refer to the Mission and Goals
of the laboratory.
Services:
Test Menu:
|
Faculty & Staff:
|
